Who Is Rajiv Mehta? Lilavati Hospital Trustee To Speak At NDTV World Summit 2026
Alain Ebobisse, Africa50 CEO, To Attend NDTV World Summit 2026. All About Him
Kriti Sanon At NDTV World Summit: A Look At Her Career And Business Ventures
Ex-CIA Director To Decode 'War In Times Of AI' At NDTV World Summit
Who Is Vikram Rai, CEO, South Asia GE Aerospace, Set To Attend The NDTV World Summit 2026
World-Class Chefs, Food And Music: The Fun Side Of NDTV World Summit 2026
AI, Consciousness And Dharma: Why Ancient Indian Wisdom Matters Now
NDTV World Summit: What To Expect From PM Modi's Keynote Address
NDTV World Summit 2026: What To Watch Out For | PM Modi, Jaishankar, AI And Global Power Shifts
A World Between Orders: What To Expect At NDTV World Summit 2026
The researchers found a way to tether HIV-fighting antibodies to immune cells, thereby creating a cell population resistant to the virus. These experiments were conducted in a laboratory and they show that the resistant cells were able to replace the cells infected with HIV.

The new technique offers a great advantage over therapies where antibodies float freely in the bloodstream at a relatively low concentration, the researchers explained. In the new study, antibodies hang on to a cell's surface, blocking HIV from accessing a crucial cell receptor and spreading the infection. The researchers plan to collaborate with investigators at City of Hope which is an independent research and treatment centre for cancer, diabetes and other life-threatening diseases in the United States to evaluate the effectiveness of this new therapy and conduct safety tests, as required by federal regulations before they decide to test this in patients.



